Acetylation reprograms MITF target selectivity and residence time.
Saved in:
| Title: | Acetylation reprograms MITF target selectivity and residence time. |
|---|---|
| Authors: | Louphrasitthiphol P; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, UK.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan., Loffreda A; Experimental Imaging Center, Ospedale San Raffaele, Milano, Italy., Pogenberg V; European Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany.; Institute of Biochemistry and Signal Transduction, University Hamburg Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Picaud S; Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, UK., Schepsky A; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, UK.; Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Friedrichsen H; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, UK., Zeng Z; MRC Institute of Genetics and Molecular Medicine, MRC Human Genetics Unit & Edinburgh Cancer Research Centre, Edinburgh, UK., Lashgari A; Department of Molecular Medicine and Cancer Research Center, Université Laval, Quebec, Canada; Endocrinology - Nephrology Axis, CHU de Québec - Université Laval Research Center, Quebec City, QC, Canada., Thomas B; Central Proteomics Facility, Sir William Dunn Pathology School, University of Oxford, Oxford, UK., Patton EE; MRC Institute of Genetics and Molecular Medicine, MRC Human Genetics Unit & Edinburgh Cancer Research Centre, Edinburgh, UK., Wilmanns M; European Molecular Biology Laboratory, Hamburg Unit, Hamburg, Germany.; University Hamburg Medical Centre Hamburg-Eppendorf, Hamburg, Germany., Filippakopoulos P; Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, UK., Lambert JP; Department of Molecular Medicine and Cancer Research Center, Université Laval, Quebec, Canada; Endocrinology - Nephrology Axis, CHU de Québec - Université Laval Research Center, Quebec City, QC, Canada., Steingrímsson E; Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Mazza D; Experimental Imaging Center, Ospedale San Raffaele, Milano, Italy.; Università Vita-Salulte San Raffaele, Milano, Italy., Goding CR; Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Headington, Oxford, UK. colin.goding@ludwig.ox.ac.uk. |
| Source: | Nature communications [Nat Commun] 2023 Sep 28; Vol. 14 (1), pp. 6051. Date of Electronic Publication: 2023 Sep 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
